BeOne Medicines (ONC) Revenue Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.94% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 4.47% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 54.05% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 50.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.07% |
| Dec 31, 2025 | 57.96% |
| Sep 30, 2025 | 53.88% |
| Jun 30, 2025 | 56.74% |
| Mar 31, 2025 | 53.88% |
| Dec 31, 2024 | 74.03% |
| Sep 30, 2024 | 69.29% |
| Jun 30, 2024 | 83.66% |
| Mar 31, 2024 | 7.45% |
| Dec 31, 2023 | 85.06% |
| Sep 30, 2023 | 104.71% |
| Jun 30, 2023 | 108.54% |
| Mar 31, 2023 | 104.89% |
| Dec 31, 2022 | 88.34% |
| Sep 30, 2022 | 97.73% |
| Jun 30, 2022 | 31.56% |
| Mar 31, 2022 | 57.94% |
| Dec 31, 2021 | 53.93% |
| Sep 30, 2021 | 56.17% |
| Jun 30, 2021 | 41.62% |
| Mar 31, 2021 | 165.04% |
| Dec 31, 2020 | 76.60% |
| Sep 30, 2020 | -25.49% |
| Jun 30, 2019 | 625.38% |
| Mar 31, 2019 | 386.25% |
| Dec 31, 2018 | 132.35% |
| Sep 30, 2018 | 239.92% |
| Jun 30, 2018 | 236.97% |
| Mar 31, 2018 | 186.84% |